1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 06 OCTOBER 2014

Cancer Drug News 06 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Oxford BioTherapeutics Instrumental In Several Of Big Pharma's ADC Developments
Industry Brief - Halaven Launches In Australia For MBC Patients
Industry Brief - ERYTECH Reports Positive Phase III Results With Graspa In ALL
Industry Brief - Incyte Earns Milestone Payment Related To Jakavi's Reimbursement In Europe
Industry Trend Analysis - UK's NICE Continues Rejection Trend With Obinutuzumab
Industry Brief - Immunovaccine Provides Update On DPX-Survivac
Industry Trend Analysis - Combinations Key To Pfizer's Immuno-Oncology Success
Industry Brief - Vosaroxin/Cytarabine Phase III Trial Fails To Meet Primary Endpoint
Industry Brief - CleveXel Licenses Two Oncology Patents From SATT Sud Est
Industry Trend Analysis - Blood-Based Diagnostic Opens New Market For Iressa
Industry Trend Analysis - Breakthrough Designation Signals More Positive Future For ARIAD
Industry Brief - Trelstar Six-Month Dosing For PCA Launches In Canada
Industry Brief - FDA Grants ODD To Halozyme's PEGPH20 For PC
Industry Brief - Insys' Pharmaceutical CBD Receives FDA ODD For Glioma
Industry Brief - BMS Reports Multiple Regulatory Milestones For Opdivo In US/EU
Industry Brief - Pharmacyclics/Servier End Pan-HDAC Inhibitor Collaboration
Industry Trend Analysis - Multiple ODDs For CytRx Cover Three Areas Of Unmet Medical Need
Industry Trend Analysis - Genentech Faces Backlash Over Cancer Drug Distribution Changes
Industry Brief - Sorrento/Lee's Pharma Enter Chinese Licensing Agreement For Anti-PD-L1 Antibody
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Brief - KHK Receives Japanese Approval For G-Lasta
Industry Brief - Positive Phase III Data Reported For Anamorelin In NSCLC Patients With Anorexia-Cachexia
Industry Brief - to-BBB Completes Management Team And Changes Name To BBB Therapeutics
Industry Brief - Baxter To Form New Global Innovation/R&D Centre For Biopharmaceuticals Business
Industry Brief - Prima BioMed To Acquire Immutep
Industry Brief - Cancer Conferences - January 2015

Table Of Contents

Cancer Drug News 06 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.